Pfizer to invest $95m in French specialty vaccine company Valneva
US pharma giant Pfizer said that it will invest $95 million in Valneva, a French specialty vaccine company, for an 8.1% stake. The two firms have signed an equity subscription agreement in this connection. Besides, they have amended the terms of their collaboration and license agreement for VLA15, a vaccine candidate for Lyme disease. Pfizer […]